Clinical Trial Update: GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for NETrin monoclonal antibodies in combination with chemotherapy and/or pembrolizumab in gynecologic cancers (endometrial and cervical …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer

Drugs mentioned

• NETrin MAbs
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: NETRIS Pharma | Conditions: Endometrial Carcinoma, Cervix Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING